Orthopediatrics (KIDS) Free Cash Flow Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.28% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 9.63% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 22.80% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 29.36% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -27.72% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -0.27% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 77.20% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -20.37% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.32% |
| 10 | Orthopediatrics | 394.83 Mn | 346.02 Mn | 43.39 Mn | 23.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.79% |
| Dec 31, 2025 | 10.56% |
| Sep 30, 2025 | 21.78% |
| Jun 30, 2025 | -1.15% |
| Mar 31, 2025 | 0.04% |
| Dec 31, 2024 | 78.34% |
| Sep 30, 2024 | -58.45% |
| Jun 30, 2024 | -6.09% |
| Mar 31, 2024 | -41.27% |
| Dec 31, 2023 | 46.99% |
| Sep 30, 2023 | -31.04% |
| Jun 30, 2023 | -3.72% |
| Mar 31, 2023 | -1.48% |
| Dec 31, 2022 | 42.52% |
| Sep 30, 2022 | -42.87% |
| Jun 30, 2022 | -8.59% |
| Mar 31, 2022 | 0.16% |
| Dec 31, 2021 | -2.44% |
| Sep 30, 2021 | -8.01% |
| Jun 30, 2021 | -10.02% |
| Mar 31, 2021 | 15.77% |
| Dec 31, 2020 | 2.75% |
| Sep 30, 2020 | -86.39% |
| Jun 30, 2020 | -15.99% |
| Mar 31, 2020 | -101.32% |
| Dec 31, 2019 | -169.04% |